372 related articles for article (PubMed ID: 23341163)
1. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.
Cantley MD; Haynes DR
Inflammopharmacology; 2013 Aug; 21(4):301-7. PubMed ID: 23341163
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases.
Dekker FJ; van den Bosch T; Martin NI
Drug Discov Today; 2014 May; 19(5):654-60. PubMed ID: 24269836
[TBL] [Abstract][Full Text] [Related]
3. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.
Wahi A; Jain P; Sinhari A; Jadhav HR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):675-702. PubMed ID: 37615708
[TBL] [Abstract][Full Text] [Related]
4. Function of histone deacetylase inhibitors in inflammation.
Grabiec AM; Tak PP; Reedquist KA
Crit Rev Immunol; 2011; 31(3):233-63. PubMed ID: 21740352
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro.
Algate K; Haynes D; Fitzsimmons T; Romeo O; Wagner F; Holson E; Reid R; Fairlie D; Bartold P; Cantley M
J Cell Biochem; 2020 Jan; 121(1):244-258. PubMed ID: 31222845
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
Bai G; Wei D; Zou S; Ren K; Dubner R
Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases.
Gatla HR; Muniraj N; Thevkar P; Yavvari S; Sukhavasi S; Makena MR
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841513
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.
Sweet MJ; Shakespear MR; Kamal NA; Fairlie DP
Immunol Cell Biol; 2012 Jan; 90(1):14-22. PubMed ID: 22024621
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of histone deacetylases as anti-inflammatory drugs.
Dinarello CA
Ernst Schering Res Found Workshop; 2006; (56):45-60. PubMed ID: 16331856
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
Hyndman KA
Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
[TBL] [Abstract][Full Text] [Related]
11. The role of histone deacetylase 3 in breast cancer.
Rahbari R; Rasmi Y; Khadem-Ansari MH; Abdi M
Med Oncol; 2022 May; 39(5):84. PubMed ID: 35578147
[TBL] [Abstract][Full Text] [Related]
12. HDAC modulation and cell death in the clinic.
Dell'Aversana C; Lepore I; Altucci L
Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
[TBL] [Abstract][Full Text] [Related]
14. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in histone deacetylase targeted cancer therapy.
Hoshino I; Matsubara H
Surg Today; 2010 Sep; 40(9):809-15. PubMed ID: 20740342
[TBL] [Abstract][Full Text] [Related]
16. Histone Deacetylase Inhibitors in Cancer Therapy.
Sun Y; Sun Y; Yue S; Wang Y; Lu F
Curr Top Med Chem; 2018; 18(28):2420-2428. PubMed ID: 30526462
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylases (HDACs) as therapeutic target for depressive disorders.
Misztak P; Pańczyszyn-Trzewik P; Sowa-Kućma M
Pharmacol Rep; 2018 Apr; 70(2):398-408. PubMed ID: 29456074
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of airway inflammation.
Adcock IM; Tsaprouni L; Bhavsar P; Ito K
Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
[TBL] [Abstract][Full Text] [Related]
19. HDACs as an emerging target in endocrine tumors: a comprehensive review.
Klieser E; Neumayer B; Di Fazio P; Mayr C; Neureiter D; Kiesslich T
Expert Rev Endocrinol Metab; 2023 Mar; 18(2):143-154. PubMed ID: 36872882
[TBL] [Abstract][Full Text] [Related]
20. Classical HDACs in the regulation of neuroinflammation.
Dai Y; Wei T; Shen Z; Bei Y; Lin H; Dai H
Neurochem Int; 2021 Nov; 150():105182. PubMed ID: 34509559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
